Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
25.60
+0.58 (2.32%)
May 2, 2025, 4:00 PM EDT - Market closed
Fresenius Medical Care AG Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Fresenius Medical Care AG stock has a target of 25, which predicts a decrease of -2.34% from the current stock price of 25.60.
Analyst Consensus: Hold
* Price targets were last updated on Jan 6, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Fresenius Medical Care AG is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Truist Securities | Truist Securities | Hold Maintains $23 → $25 | Hold | Maintains | $23 → $25 | -2.34% | Jan 6, 2025 |
Truist Securities | Truist Securities | Hold Maintains $22 → $23 | Hold | Maintains | $22 → $23 | -10.16% | Oct 7, 2024 |
Truist Securities | Truist Securities | Hold Maintains $24 → $22 | Hold | Maintains | $24 → $22 | -14.06% | Jul 31, 2024 |
Truist Securities | Truist Securities | Hold Maintains $21 → $24 | Hold | Maintains | $21 → $24 | -6.25% | May 15, 2024 |
Truist Securities | Truist Securities | Hold Maintains $24 → $21 | Hold | Maintains | $24 → $21 | -17.97% | Apr 15, 2024 |
Financial Forecast
Revenue This Year
19.95B
from 19.34B
Increased by 3.18%
Revenue Next Year
20.67B
from 19.95B
Increased by 3.62%
EPS This Year
3.71
from 1.83
Increased by 102.49%
EPS Next Year
4.09
from 3.71
Increased by 10.29%
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 21.4B | 22.4B | 23.7B | ||
Avg | 20.0B | 20.7B | 21.4B | ||
Low | 18.8B | 19.2B | 19.9B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 10.6% | 12.4% | 14.5% | ||
Avg | 3.2% | 3.6% | 3.4% | ||
Low | -2.8% | -3.9% | -3.9% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.45 | 5.33 | 6.38 | ||
Avg | 3.71 | 4.09 | 4.70 | ||
Low | 2.13 | 2.30 | 3.55 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 143.3% | 43.9% | 56.2% | ||
Avg | 102.5% | 10.3% | 15.0% | ||
Low | 16.2% | -37.9% | -13.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.